(Q46411324)

22 December 2017

title

Rats maintained chronically on buprenorphine show reduced heroin and cocaine seeking in tests of extinction and drug-induced reinstatement (English)

1 reference

22 December 2017

author name string

Robert E Sorge

series ordinal

1

1 reference

22 December 2017

Heshmat Rajabi

series ordinal

2

1 reference

22 December 2017

Jane Stewart

series ordinal

3

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

22 December 2017

published in

Neuropsychopharmacology

1 reference

22 December 2017

volume

30

1 reference

22 December 2017

issue

9

1 reference

22 December 2017

page(s)

1681-1692

1 reference

22 December 2017

A role for the prefrontal cortex in stress- and cocaine-induced reinstatement of cocaine seeking in rats

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Evidence for opiate-dopamine cross-sensitization in nucleus accumbens: studies of conditioned reward

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Opiate infusion into nucleus accumbens: contrasting effects on motor activity and responding for conditioned reward

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Mesolimbic dopamine neurotransmission is increased by administration of mu-opioid receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Plasmalemmal mu-opioid receptor distribution mainly in nondopaminergic neurons in the rat ventral tegmental area

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Combating opiate dependence: a comparison among the available pharmacological options

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Effects of buprenorphine sublingual tablet maintenance on opioid drug-seeking behavior by humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Illicit drug use and injection practices among drug users on methadone and buprenorphine maintenance treatment in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Morphine-induced activation of A10 dopamine neurons in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

A controlled trial of buprenorphine treatment for opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Glutamate systems in cocaine addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Synergism between buprenorphine and cocaine on the rotational behavior of the nigrally-lesioned rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Pharmacologic treatments for heroin and cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Cocaine conditioned place preference is attenuated by chronic buprenorphine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

A 2.5-year follow-up of cocaine use among treated opioid addicts. Have our treatments helped?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Treating opioid dependence. Growing implications for primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Understanding polydrug use: review of heroin and cocaine co-use

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Methadone maintenance reduces heroin- and cocaine-induced relapse without affecting stress-induced relapse in a rodent model of poly-drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Buprenorphine-induced alterations of cocaine's reinforcing effects in rhesus monkey: a dose-response analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Historical review: Molecular and cellular mechanisms of opiate and cocaine addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Cocaine self-administration appears to be mediated by dopamine uptake inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Monoamine transporters and psychostimulant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Buprenorphine: dose-related effects on cocaine and opioid use in cocaine-abusing opioid-dependent humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Effects of opioid and dopamine receptor antagonists on relapse induced by stress and re-exposure to heroin in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Interactions between opioids and cocaine on locomotor activity in rats: influence of an opioid's relative efficacy at the mu receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Stress and relapse to drug seeking: studies in laboratory animals shed light on mechanisms and sources of long-term vulnerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Comparison of buprenorphine and methadone in the treatment of opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Hair testing and self-report of cocaine use by heroin users

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Behavioral pharmacology of buprenorphine, with a focus on preclinical models of reward and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Reassessment of buprenorphine in conditioned place preference: temporal and pharmacological considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Clinical pharmacology of buprenorphine: ceiling effects at high doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

Pharmacotherapeutic interventions for cocaine abuse. Matching patients to treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

7 January 2021

Blockade of stress-induced but not cocaine-induced reinstatement by infusion of noradrenergic antagonists into the bed nucleus of the stria terminalis or the central nucleus of the amygdala.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

7 January 2021

Drug-induced reinstatement to heroin and cocaine seeking: a rodent model of relapse in polydrug use.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

7 January 2021

Chronic morphine treatment alters NMDA receptor-mediated synaptic transmission in the nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

7 January 2021

Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

7 January 2021

Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

7 January 2021

Relapse to heroin-seeking in rats under opioid maintenance: the effects of stress, heroin priming, and withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300712

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300712

1 reference

22 December 2017

release_uztmdv5fcbedxn26tnsntqsnpq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uztmdv5fcbedxn26tnsntqsnpq

24 November 2022

mapped directly with Wikidata item

1 reference

22 December 2017